FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/04/085556 [Registered on: 24/04/2025] Trial Registered Prospectively
Last Modified On: 27/11/2025
Post Graduate Thesis  No 
Type of Trial  Observational 
Type of Study   Cohort Study 
Study Design  Other 
Public Title of Study   Upgrading Norms for Growth and Development Assessment of Indian Children (UNNATI) 
Scientific Title of Study   India Child Growth Standards Research Initiative: A Prospective Cohort Study to Develop Growth Standards in 0 to 24 months Indian Children 
Trial Acronym  UNNATI 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Aparna Mukherjee  
Designation  Scientist F  
Affiliation  Indian Council of Medical Resarch  
Address  First floor, New Building, Clinical Studies & Trial Unit, Division of Development Research, V Ramalingaswami Bhawan ICMR Headqauters Ansari Nagar

New Delhi
DELHI
110029
India 
Phone  9968408999  
Fax    
Email  aparna.sinha.deb@icmr.gov.in  
 
Details of Contact Person
Scientific Query
 
Name  Dr Amlin Shukla  
Designation  Scientist E 
Affiliation  Indian Council of Medical Resarch  
Address  Room No. 305, Division of Delivery Research
V Ramalingaswami Bhawan ICMR Headqauters Ansari Nagar
New Delhi
DELHI
110029
India 
Phone  8447125128  
Fax    
Email  amlin.shukla@icmr.gov.in   
 
Details of Contact Person
Public Query
 
Name  Dr Aparna Mukherjee 
Designation  Scientist F 
Affiliation  Indian Council of Medical Resarch 
Address  First floor, New Building, Clinical Studies & Trial Unit, Division of Development Research, V Ramalingaswami Bhawan ICMR Headqauters Ansari Nagar

New Delhi
DELHI
110029
India 
Phone  9968408999  
Fax    
Email  aparna.sinha.deb@icmr.gov.in  
 
Source of Monetary or Material Support  
Indian Council of Medical Research, New Delhi 
 
Primary Sponsor  
Name  Indian Council of Medical Research, New Delhi 
Address  ICMR Headquarters, Ansari Nagar, New Delhi, India 
Type of Sponsor  Government funding agency 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 6  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sadhana Joshi  Interactive Research School for Health Affairs (IRSHA)  Bharati Hospital and Research centre, Satara Road, Dhankawadi
Pune
MAHARASHTRA 
8007945167

srjoshi62@gmail.com 
Dr C Sai Ram  National Institute of Nutrition (NIN)  Jamai-Osmania
Hyderabad
TELANGANA 
9618774603

challa.sv@icmr.gov.in 
Dr Samiran Bisai  Sidho-Kanho-Birsha University  P.O-Purulia Sainik School, Ranchi Road
Puruliya
WEST BENGAL 
9434021821

samiran.bisai@skbu.ac.in 
Dr Sunita Taneja  Society for Applied Studies (SAS)  45, Kalu Sarai
New Delhi
DELHI 
9811206456

sunita.taneja@sas.org.in 
Dr Pratibha Dwarkanath  St. Johns Research Institute (SJRI)  St. Johns National Academy of Health Sciences
Bangalore
KARNATAKA 
9880714118

pratibha@sjri.res.in 
Dr Manoj Kumar Das  The INCLEN Trust International and NEIGRIHMS  F-1/5, Second Floor, Okhla Industrial Area, Phase I
New Delhi
DELHI 
9810203768

manoj@inclentrust.org 
 
Details of Ethics Committee  
No of Ethics Committees= 6  
Name of Committee  Approval Status 
The INCLEN Trust International  Approved 
Institutional Ethical Committee National Institute of Nutrition (ICMR)  Approved 
Institutional Ethics Committee, Bharati Vidyapeeth Deemed University  Approved 
Sidho Kanho Birsha University  Approved 
Society for Applied Studies  Approved 
St Johns Research Institute, Bangalore   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  Child Growth and Development 
 
Intervention / Comparator Agent  
Type  Name  Details 
 
Inclusion Criteria  
Age From  1.00 Day(s)
Age To  24.00 Month(s)
Gender  Both 
Details  Parental, Family and Environmental Criteria:

1. Spontaneously conceived term singleton birth with gestational age equal to or more than 37 completed weeks (259 days) and less than 42 completed weeks (294 days).

2. No significant illness diagnosed during pregnancy, such as severe anemia, pregnancy-induced hypertension, gestational diabetes mellitus, hypothyroidism, obesity, any chronic or severe medical illness.

3. No history of consumption of tobacco, alcohol, or other substance uses in any form during this pregnancy, and smoking inside the house by any family members.

4. 15 years or more of formal parental education.

5. Family willing for frequent contacts.

Child characteristics:

1. Adequate adherence to criteria for a healthy growth environment including exclusive breastfeeding for 6 months, appropriate complementary feeding, and all the components of the nurturing care framework to ensure healthy caregiving environment.

2. Appropriate body composition
 
 
ExclusionCriteria 
Details  1. Congenital abnormalities that may affect growth such as congenital heart disease, neural tube defects based on antenatal USG or post-delivery clinical evaluation or any other major malformation.

2. Birth complications such as birth asphyxia, sepsis or any other morbidity that require longer hospital stay.

3. Any major illness diagnosed during the study period.

4. Major adverse environmental influences like child abuse.

5. Maternal death any time during the study period.

 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Growth standards for children from 0-24 months of age.
Weight for age (Z Score), Length for age (Z score), Weight for length (Z score), BMI for age and growth velocity charts will be developed 
Anthropometric data will be collected at Birth, 1-2,4,6,8 weeks of age and 3,4,5,6,7,8,9,10,11,12,14,16,18,20,22,24 months of age.

 
 
Secondary Outcome  
Outcome  TimePoints 
Neuro-developmental assessment will be done by WHO-GSED (Global Scale for Early Development).
Growth Charts for Small for Gestational Age babies (0-24 months) Weight for age (Z Score), Length for age (Z score), Weight for length (Z score), BMI for age & growth velocity charts will be developed
 
Neuro-development assessment data will be collected at the following time points: 1, 3, 6, 9, 12, 15, 18, 21 & 24 months of age.
Assessment time-points will be similar for SGA & AGA babies
 
 
Target Sample Size   Total Sample Size="600"
Sample Size from India="600" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   01/05/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="3"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Healthy growth from conception through early life is crucial for laying a strong foundation for future physical health, work productivity, and cognitive capacity. Assessing children’s growth is crucial for evaluating the health and socioeconomic development of communities where they live. Currently, the most widely used standards for the assessment of growth and development of children are the World Health Organization growth standards based on the Multicenter Growth Reference Study (MGRS) conducted over 20 years ago. Since then, practices constituting an optimal environment for child growth have evolved. Also, the Indian data for WHO-MGRS study, collected from a single centre at South Delhi is not considered as representative of the Indian population by many critics. Therefore, a prospective cohort study with children from six regions of the country has been planned to measure childhood growth and development, from 0-24 months, in an environment without major biological, socio-behavioral, and economic constraints to growth. Other objectives of the study are to develop normative neurodevelopmental charts for Indian Children 0-24 months of age and growth curves for term Small for Gestational Age (SGA) babies from 0-24 months of age.

 

Pregnant women <37 weeks of gestation (with dating ultrasound available) will be screened to rule out major biological, socio-behavioral and economic constraints to growth of fetus. The term infants born of such eligible women, with no major congenital anomalies or birth complications, will be enrolled after taking informed, written consent from parent/s. A total of 300 boys and 300 girls will be enrolled from 6 sites. The enrolled infants will be followed every fortnightly from birth till 2 months, monthly till 12 months and then bimonthly till 24 months of age to record the anthropometric indices

such as weight, length, head circumference and mid upper arm circumference. Mothers/ care givers will be counselled on these visits about nurturing care framework that consists of good health, adequate nutrition, safety and security, responsive caregiving and opportunities for learning. WHO-GSED (Global Scale for Early Development- long and short forms) will be administered to all enrolled children to assess the development scores. The expected duration of the study is 3.5 years


 
Close